The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017 – The Lancet Infectious Diseases
Researchers are calling for urgent investment in the prevention of a devastating emerging disease that kills tens of thousands of people each year.
A global systematic review led by the University of Otago’s Professor John Crump and Dr Christian Marchello, of the Centre for International Health, and published today in the Lancet Infectious Diseases journal reports on the frequency of a range of serious complications and very high risk for death among patients with found non-typhoidal Salmonella invasive disease.
Non-typhoidal Salmonella invasive disease is an emerging neglected infectious disease that affects mainly young children and immunocompromised adults in sub-Saharan Africa. It affects more than half a million people a year and is fatal in 15 per cent of cases – about 77,500 deaths worldwide annually.
On behalf of the global Vacc-iNTS Consortium, Professor Crump, Dr Marchello, and Dr Megan Birkhold, of the University of Maryland School of Medicine, investigated the complications and mortality associated with the disease. The Consortium – which has 12 partners from eight different countries including Burkina Faso, Ghana, Kenya and Malawi aims to advance the clinical development of an innovative vaccine to tackle the serious and often fatal infection.
“Despite being a leading serious bacterial disease in countries of sub-Saharan Africa, non-typhoidal Salmonella invasive disease is not widely known or appreciated and burden of disease estimates need improving,” Professor Crump says.
In high-income countries, like New Zealand, non-typhoidal Salmonella is best known as a cause of food poisoning, where patients usually recover without treatment.
“In sub-Saharan Africa, young children and immunocompromised adults are infected in the bowel but do not usually get diarrhoea. Instead, because of concurrent health problems like malnutrition, malaria, HIV, and other reasons that are not well understood, many people get invasion to the blood and very serious illness called blood poisoning or sepsis, that often leads to death.”
The Vacc-iNTS Consortium is working on phase 1 trials of a candidate vaccine, but global support, funding and awareness are needed.
“Our study has shown that a range of very serious complications are frequent among non-typhoidal Salmonella invasive disease patients and the disease has a 15 per cent fatality ratio. If you compare this case fatality ratio with 0.2 per cent for malaria and two per cent for typhoid fever, we start to appreciate how deadly non-typhoidal Salmonella invasive disease is and why we must do more to prevent transmission,” Professor Crump says.
The study refines the burden of the disease and justifies vaccine development efforts.
“We need to re-double efforts to develop and evaluate vaccines to prevent this terrible disease.”
Equally as important is the need for more research into non-vaccine prevention.
“We need to understand how the bacteria responsible are transmitted so that we can interrupt transmission using non-vaccine approaches. For example, are most people exposed via contaminated water or food, in which case improvements in the safety of water or food by better sanitation could help to prevent infection? Is the main reservoir in people or animals, in other words do we need to control human faeces or animal faeces as well to prevent this?”
Original Article: Urgent investment needed in deadly disease
More from: University of Otago
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Non-typhoidal Salmonella invasive disease
- FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy ...
- Impact of COVID-19-related nonpharmaceutical interventions on diarrheal diseases and zoonotic Salmonella
Non-pharmaceutical interventions (NPIs) have been proven effective in reducing the spread of COVID-19, but their broader impact on gastrointestinal disorders remains poorly studied. Non-typhoidal ...
- Study highlights heavy global burden of infectious diseases
The three pathogens with the largest observed impact were those causing tuberculosis (TB, 65.1 million DALYs), malaria (53.6 million), and HIV or AIDs (52.1 million). Malaria parasites were the ...
Go deeper with Google Headlines on:
Non-typhoidal Salmonella invasive disease
[google_news title=”” keyword=”non-typhoidal Salmonella invasive disease” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Non-typhoidal Salmonella invasive disease vaccine
- Harnessing mRNA Vaccine Technology for Disease Prevention
World Immunization Week is observed every year during the last week of April to raise awareness about the potential of vaccines to prevent disease ... unresponsive non-muscle invasive bladder ...
- Vaccine-preventable diseases spike
KUALA LUMPUR: Misinformation about vaccines has led to a huge increase in vaccine-preventable diseases, with almost a 1,000% increase in the number of measles cases compared to five years ago.
- ‘More than 10,000 children at risk of brain-swelling disease’ if MMR vaccine uptake ‘does not improve’ an expert warns
The paper suggested that the MMR vaccine might be associated with autism and a form of bowel disease. It led to a sharp decline in vaccination rates. Even at the time, the research was ...
- Impact of COVID-19-related nonpharmaceutical interventions on diarrheal diseases and zoonotic Salmonella
Non-pharmaceutical interventions (NPIs) have been proven effective in reducing the spread of COVID-19, but their broader impact on gastrointestinal disorders remains poorly studied. Non-typhoidal ...
- Measles is a preventable disease: What parents need to know about measles, vaccines
(Dreamstime/TNS) Measles is a highly contagious disease caused by the measles virus. The infection can lead to serious and sometimes fatal complications. Fortunately, measles is a vaccine ...
Go deeper with Google Headlines on:
Non-typhoidal Salmonella invasive disease vaccine
[google_news title=”” keyword=”non-typhoidal Salmonella invasive disease vaccine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]